Interní Med. 2008; 10(3): 117-120

What is new in new guidelines FOR diagnosis and treatment of lipid disorders in adulthood

prof. MUDr. Helena Vaverková CSc1, doc. MUDr. Vladimír Soška CSc2,3
1 III. interní klinika FN a LF UP Olomouc
2 Oddělení klinické a radiační onkologie, FN u svaté Anny v Brně
3 Centrum pro diagnostiku a léčbu dyslipidemií, FN u sv. Anny v Brně

New guidelines of diagnosis and treatment of lipid disorders in adulthood, prepared by the committee of the Czech society of atherosclerosis are based on results of new epidemiological and interventional studies with hypolipidemics and on new knowledge on pathophysiology of lipid disorders. They introduce new recommended target levels of LDL-cholesterol, inform about the use of apolipoprotein and non-HDL cholesterol as secondary targets in selected groups of individuals (with diabetes mellitus, metabolic syndrome, hypertriglyceridemy, cardiovascular disease with relatively low level of LDL-cholesterol). They improve the estimation of individual risk of cardiovascular complications taking into account both classical and some of new risk factors and present also the options of detection of preclinical atherosclerosis. Priorities of treatment, algorhytms of treatment of individual disorders (monotherapy and combination of hypolipidemics) are discussed as well as nonpharmacological intervention in patients with lipid disorders.

Keywords: lipid disorders, LDL-cholesterol, apolipoprotein B, cardiovascular disease, hypolipidemics

Published: May 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vaverková H, Soška V. What is new in new guidelines FOR diagnosis and treatment of lipid disorders in adulthood. Interní Med. 2008;10(3):117-120.
Download citation

References

  1. Cífková R, Býma S, Češka R, Horký K, Karen I, Kunešová M, Králíková E, Rosolová H, Roztočil K, Soška V, Škrha J. Prevence kardiovaskulárních onemocnění v dospělém věku. Společné doporučení českých odborných společností. Vnitřní lék 2005; 51: 1021-1036.
  2. Cor Vasa 2007; 49(3): K73-K86.
  3. Čas Lék čes 2007; 146(6): I-XV.
  4. DMEV 2007; 10(2): 106-120.
  5. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Four Joint Task Force of European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehab 2007; 14 (Suppl 2): E1-E40.
  6. Vaverková H, Soška V, Rosolová H, Češka R, Cífková R, Freiberger T, Piha J, Poledne R, Štulc T, Urbanová Z, Vráblík M. Doporučení pro diagnostiku a léčbu dyslipidemií v dospělosti, vypracovaná výborem České společnosti pro aterosklerózu. Vnitřní lék 2007; 53(2): 181-197.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.